Psychotropic prescription use by community-dwelling elderly in the United States

Journal of the American Geriatrics Society

Volumn 51, Issue 5, 2003, Pages 671-677

  Aparasu, Rajender R ^a   Mort, Jane R ^a   Brandt, Heather ^a  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Community dwelling; Elderly; Psychotropic; United States survey

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CENTRAL STIMULANT AGENT; HYPNOTIC SEDATIVE AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; ANXIETY DISORDER; ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; DEPRESSION; DISEASE PREDISPOSITION; DRUG USE; DRUG UTILIZATION; EDUCATION; ELDERLY CARE; FEMALE; GENDER; HEALTH INSURANCE; HEALTH STATUS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRESCRIPTION; RACE; RETROSPECTIVE STUDY; SEDATION; UNITED STATES;

AGED; AGED, 80 AND OVER; DRUG UTILIZATION; FEMALE; GERIATRICS; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; MALE; PSYCHOTROPIC DRUGS; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 0038408669     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0579.2003.00212.x     Document Type: Article

References (29)

1. Gurvich T, Cunningham JA. Appropriate use of psychotropic drugs in nursing homes. Am Fam Physician 2000;61:1437-1446.
2. Naranjo CA, Herrmann N, Mittmann N et al. Recent advances in geriatric psychopharmacology. Drugs Aging 1995;7:184-202.
3. Health Care Financing Administration Interpretive Guidelines. Guidance to surveyors-long term care facilities. 483.25(1)(1), tag number F329 Unnecessary drugs, rev 274. 1007-99; 483.25(1)(2)(i)-(ii), tag numbers F330-1 Antipsychotic drugs, rev 274, 1007-99 483.60(c)(2), tag number F429 Drug regimen review, rev 1007-99. Washington, DC: Health Care Financing Administration, 1999.
4. Dealberto MJ, Seeman T, McAvay GJ et al. Factors related to current and subsequent psychotropic drug use in an elderly cohort. J Clin Epidemiol 1997;50:357-364.
5. Helling DK, Lemke JH, Semla TP et al. Medication use characteristics in the elderly: The Iowa 65+ rural health study. J Am Geriatr Soc 1987;35:4-12.
6. Vazquez-Barquero JL, Diez Manrique JF, Pena C et al. Patterns of psychotropic drug use in a Spanish rural community. Br J Psychiatry 1989;155:633-641.
7. Kung F, Gibson SJ, Helme RD. Factors associated with analgesic and psychotropic medications use by community-dwelling older people with chronic pain. Aust N Z J Public Health 1999;23:471-474.
8. Gleason PP, Schulz R, Smith NL et al. Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med 1998;13:243-250.
9. Olfson M, Pincus HA. Use of benzodiazepines in the community. Arch Intern Med 1994;154:1235-1240.
10. Stewart RB, Marks RG, Padgett PD et al. Benzodiazepine use in an ambulatory elderly population: A 14-year overview. Clin Ther 1994;16:118-124.
11. Swartz M, Landerman R, George LK et al. Benzodiazepine anti-anxiety agents: Prevalence and correlates of use in a southern community. Am J Public Health 1991;81:592-596.
12. Blazer D, Hybels C, Simonsick E et al. Sedative, hypnotic, and antianxiety medication use in an aging cohort over ten years: A racial comparison. J Am Geriatr Soc 2000;48:1073-1079.
13. Blazer DG, Hybels CF, Simonsick EM et al. Marked differences in antide-pressant use by race in an elderly community sample: 1986-1996. Am J Psychiatry 2000;157:1089-1094.
14. Cohen J. Sample design of the 1996 Medical Expenditure Survey Household Component (MEPS Methodology Report No. 2; AHCPR Publication no. 97-0027). Rockville, MD: Agency for Health Care Policy and Research, 1997
15. Cohen SB, DiGaetano R, Goksel H. Estimation procedures in the 1996 Medical Expenditure Panel Survey Household Component (MEPS Methodology Report No. 5; AHCPR Publication no. 99-0027). Rockville, MD: Agency for Health Care Policy and Research, 1999.
16. Survey Instruments and Associated Documentation, April 2002 [On-line]. Rockville, MD: Agency for Healthcare Research and Quality. Available at http://www.meps.ahrq.gov/survey.htm Accessed August 22, 2002.
17. Moeller JF, Stagnitti MN, Horan E. Outpatient Prescription Drugs. Data Collection and Editing in the 1996 Medical Expenditure Survey (HC010A) (MEPS Methodology Report No. 12; AHRQ Publication no. 010002). Rockville, MD: Agency for Health Care Policy and Research, 2001.
18. Mort JR, Aparasu RR. Prescribing potentially inappropriate psychotropic medications to the ambulatory elderly. Arch Intern Med 2000;160:2825-2831.
19. Hussar DA. New drugs of 1996. J Am Pharm Assoc 1997;37:192-228.
20. Andersen R, Newman J. Societal and individual determinants of medical care utilization in the United States. Milbank Q 1973;51:95-124.
21. Gray SL, Hanlon JT, Fillenbaum GG et al. Predictors of nutritional supplement use by the elderly. Pharmacotherapy 1996;16:715-720.
22. Mamdani MM, Parikh SV, Austin PC et al. Use of antidepressants among elderly subjects: Trends and contributing factors. Am J Psychiatry 2000;157:360-367.
23. Taylor S, McCracken CFM, Wilson KCM et al. Extent and appropriateness of benzodiazepine use. Br J Psychiatry 1998;173:433-438.
24. Egberts ACG, Leufkens HGM, Hofman A et al. Incidence of antidepressant drug use in older adults and association with chronic diseases: The Rotterdam study. Int Clin Psychopharmacol 1997;12:217-223.
25. Weissman MM. Advances in psychiatric epidemiology. Rates and risks for major depression. Am J Public Health 1987;77:445-451.
26. Prigerson HG, Maciejewski PK, Rosenheck RA. The effects of marital dissolution and marital quality on health and health service use among women. Med Care 1999;37:858-873.
27. Stallones L, Marx MB, Garrity TF. Prevalence and correlates of depressive symptoms among older U.S. adults. Am J Prev Med 1990;6:295-303.
28. Lillard LA, Rogowski J, Kington R. Insurance coverage for prescription drugs: Effects on use and expenditures in the Medicare population. Med Care 1999;37:926-936.
29. Hanlon JT, Landerman LR, Wall WE et al. Is medication use by community-dwelling elderly people influenced by cognitive function? Age Aging 1996;25:190-196.